Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

UltraCor™ Twirl™ Breast Tissue Marker

K-Number: K243642 · 2025-03-24

Decision Date2025-03-24
Product CodeNEU
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

UltraCor™ Twirl™ Breast Tissue Marker is a medical device manufactured by Bard Peripheral Vascular, Inc.. It received FDA 510(k) clearance on 2025-03-24 under approval number K243642. The device is classified under product code NEU. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the UltraCor™ Twirl™ Breast Tissue Marker?

UltraCor™ Twirl™ Breast Tissue Marker is a medical device that received FDA 510(k) clearance on 2025-03-24. It is manufactured by Bard Peripheral Vascular, Inc.. The 510(k) number is K243642.

When was UltraCor™ Twirl™ Breast Tissue Marker approved by the FDA?

UltraCor™ Twirl™ Breast Tissue Marker received FDA 510(k) clearance on 2025-03-24, under approval number K243642.

What company makes UltraCor™ Twirl™ Breast Tissue Marker?

UltraCor™ Twirl™ Breast Tissue Marker is manufactured by Bard Peripheral Vascular, Inc..

What is the FDA product code for UltraCor™ Twirl™ Breast Tissue Marker?

The FDA product code for UltraCor™ Twirl™ Breast Tissue Marker is NEU.

Related Clinical Trials

Other Devices by Bard Peripheral Vascular, Inc.

View all 22 devices →

Related Devices (Code: NEU)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.